NCT00333086View on ClinicalTrials.gov

A Study of Letrozole in the Treatment of Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

June 30, 2006

Conditions
Recurrent and Metastatic Endometrial Cancer
Interventions
DRUG

Letrozole

Trial Locations (1)

Unknown

Novartis Investigative Site, Heidelberg

Sponsors
All Listed Sponsors
collaborator

Canadian Cancer Trials Group

NETWORK

lead

Novartis Pharmaceuticals

INDUSTRY